Simulations Plus

A client was anticipating a new FDA indication for their product that would allow it to be used as a first-line therapy.

A client needed a novel program to re-engage with their key opinion leaders (KOLs) who could serve on a speaker bureau.

A client’s cardiopulmonary/respiratory team needed to develop, design, and execute a half-day Regional Advisory Board.

A client was new to the market and lacked knowledge of their customers and key opinion leaders (KOLs) in the field.

A global medical affairs client was stretched thin: their internal and field-based medical staff couldn’t be everywhere at once, and they needed help keeping on top of the material presented at key medical conferences.

A client had an asset in clinical development that showed activity against multiple tumor types.

A client needed new patient cases to illustrate recent indication updates to their label. They also wanted to consolidate new and existing case studies into a single, streamlined guide with a new, updated look.

A client’s inflammation medical affairs team wanted to introduce their business unit as an emerging leader with a robust inflammation pipeline at annual global IBD and RA conferences.

Nonalcoholic Fatty Liver Disease, or NAFLD, studies present unique enrollment challenges that Pro-ficiency directly addresses.